Abstract:Over the past decade, clinicians, neurologists and neurosurgeons have been seeking all possible logical or empirical methods for improving the plight of the patient suffering from a massive stroke. As a result of this emphasis, an inroad has been made into the previous fatalistic attitude. Much has changed since Penfield commented, "The right of the aged and the hypertensive to die from apoplectic stroke undisturbed has been unchallenged for a very long time." I am keenly aware of the many misgivings and reservations pertaining to any therapy that is advocated for the acute and subacute phases of cerebrovascular ischemia or infarction, with or without an associated thrombosis or embolism. During the past few years, we have witnessed the ebb and flow of interest in stellate ganglion blocks; papaverine; nicotinic acid; intravenous histamine, procaine, aminophylline, or bicarbonate; inhalation of external or autogenous carbon dioxide; and anticoagulants. Each of these forms of therapy has been associated with a variable measure of success, as described in enthusiastic reports by capable observers. On occasion, the response of individual patients has been quite dramatic. The enthusiasm aroused for such therapy was dampened in short order, however, by a volley of criticisms voiced by other authorities. The greatest objections concerned the unpredictable course of acute nonhemorrhagic stroke in any given patient, and the failure of the treatment being advocated to lower the rates of morbidity and mortality significantly as compared with the rates in control groups of patients. Inasmuch as the author also found himself in the position of voicing similar arguments to his own colleagues, he waited two years after observing the striking effects of adrenal steroids in the first patient of his series before feeling justified in reporting these experiences in the form of a paper which includes the data on additional cases of favorable response observed in the interim. To date, the article by Russek ei al. (1) appears to be the only one in the standard literature dealing exclusively with the use of cortisone in the immediate treatment of apoplectic stroke. Very few studies have come to my attention in which the adrenocortical steroids were actively employed in the subacute hemiplegic phase of stroke (2, 3). Several reviews were published in 1956 and 1957 dealing with the management of cerebrovascular accidents; in 1 instance (4) no reference was made to the use of hormones, and in the other 2 only a sentence was devoted to the entire subject (5, 6). Indeed, the value of such therapy in cerebral infarction has actually been denied in some quarters (7). It should be emphasized that the use of cortisone and its analogs is not advo-

Electrochemical Selection of G-Quadruplex-Binding Ligands Based on Structure-Switching of Telomeric Dna

Simple and Fast Screening of G-quadruplex Ligands with Electrochemical Detection System.

Stabilizing Parallel G-Quadruplex Dna by A New Class of Ligands: Two Non-Planar Alkaloids Through Interaction in Lateral Grooves

Ligand Binding to Dynamically Populated G‐Quadruplex DNA

Targeting Human Telomeric G-Quadruplex with Perfluoroalkyl Metal Phthalocyanine Derivatives

Molecular Recognition and Imaging of Human Telomeric G-Quadruplex DNA in Live Cells: A Systematic Advancement of Thiazole Orange Scaffold To Enhance Binding Specificity and Inhibition of Gene Expression

Single-Molecule Analysis of Human Telomere Sequence Interactions with G-quadruplex Ligand.

Xanthone derivatives as potential telomeric G-quadruplex stabilizing and cytotoxic agents: Effects of substitution on quadruplex binding affinity and cytotoxicity

Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations

Enantioselective Diels–Alder Reactions with G‐Quadruplex DNA‐Based Catalysts

Investigation of Non-Covalent Interaction of Natural Flexible Cyclic Molecules with Telomeric RNA G-quadruplexes by Electrospray Ionization Mass Spectrometry.

Electrochemical Investigation of Heterogeneous Affinity Behaviour of Methylene Blue and G‐quadruplex

Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands

A CD Study of a Structure-Based Selection of N-Heterocyclic Bis-Carbene Gold(I) Complexes as Potential Ligands of the G-Quadruplex-Forming Human Telomeric hTel23 Sequence

Human telomere double G-quadruplex recognition by berberine-bisquinolinium imaging conjugates in vitro and in cells

SUPPORTIVE ADRENOCORTICAL STEROID THERAPY IN ACUTE AND SUBACUTE CEREBROVASCULAR ACCIDENTS, WITH PARTICULAR REFERENCE TO BRAIN‐STEM INVOLVEMENT

Probing G-quadruplex-ligand binding using DNA intrinsic fluorescence

Conformation of G-quadruplex Controlled by Click Reaction

Promoting the Formation and Stabilization of Human Telomeric G-quadruplex DNA, Inhibition of Telomerase and Cytotoxicity by Phenanthroline Derivatives.

Chemical targeting of G-quadruplexes in telomeres and beyond for molecular cancer therapeutics

Binding of berberine derivates to G-quadruplex: insight from a computational study